12:00 AM
 | 
Apr 19, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Gemzar gemcitabine: Phase III data

In a U.K. Phase III trial in 410 patients, Gemzar plus cisplatin significantly increased median OS vs. Gemzar alone (11.7 vs. 8.1 months, p<0.001). The combination also...

Read the full 112 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >